The following article requires a subscription:



(Format: HTML)

OBJECTIVE: To determine risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa.

METHODS: Patients with cultures (any site) positive for P aeruginosa, susceptible to ciprofloxacin, between January 1993 and December 1996 were identified using a computerized database. Factors predictive of emergence of ciprofloxcin resistance in P aeruginosa strains isolated from the same cultured site, within 21 days of the initial culture, were determined. Factors considered included length of stay prior to initial P aeruginosa culture, isolation site, initial minimum inhibitory concentration (MIC), antibiotic area under the 24-hour concentration curve (AUC24), total area under the 24-hour inhibitory concentration curve ([AUIC24] AUC24/MIC summed for all active drugs), antibiotic(s) used as dichotomous variables (yes/no), and use of monotherapy or combination therapy.

RESULTS: Of 635 patients, 43 (7%) subsequently had ciprofloxacin-resistant P aeruginosa isolated. Four significantly differing patient groups were identified: group 1, P aeruginosa isolates from all sites other than the respiratory tract, treated with any drugs; group 2, respiratory tract isolates treated with drugs other than ciprofloxacin; group 3, respiratory tract isolates treated with ciprofloxacin at AUIC24 >110 ([mu]g[middle dot]h/mL)/[mu]g/mL); and group 4, respiratory tract isolates treated with ciprofloxacin at AUIC24 <=110 ([mu]g[middle dot]h/mL)/[mu]g/mL. The observed percentage resistant was a contnuous function of prior length of stay in all four groups. Respiratory tract isolates had higher rates of ciprofloxacin resistance (12%) than isolates from other infection sites (4%). Respiratory tract isolates exposed to ciprofloxacin at AUIC24 <=110 ([mu]g[middle dot]h/mL)/[mu]g/mL had the highest resistance (17%). At AUIC24 >110 ([mu]g[middle dot]h/mL)/[mu]g/mL, resistance was decreased to 11%, a rate similar to that seen in respiratory isolates not exposed to ciprofloxacin (7%).

CONCLUSIONS: Application of pharmacokinetic and pharmacodynamic principles to dosing of ciprofloxacin may reduce the risk of ciprofloxacin resistance to the level seen in isolates exposed to other agents

Copyright (C) 2000 SLACK Incorporated